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LeMaistre Installed as President;
Petersdorf Elected Vice PresidentC. Fred LeMaistre, MD, has been
installed as President of the American
Society for Blood and Marrow Trans-
plantation. He is the Physician-in-
Chief Hematology and Vice Presi-
dent at Sarah Cannon in Nashville,
Tennessee.
Efﬁe W. Petersdorf, MD, who is
a Member of the Division of Clinical
Research at the Fred Hutchinson Cancer
Research Center; a Professor of Medi-
cine at the University of Washington
School of Medicine, Seattle and an
Attending Physician of clinical bone
marrow transplant services at the Fred
Hutchinson Cancer Research Center and
Seattle Cancer Care Alliance, where she
is also HLA attending, is the newly
elected and installed Vice President, to
become President in 2015.
The installation of new ofﬁcers and
directors occurred at the Society’s
annual business meeting, the 2013 BMT
Tandem Meetings, on Feb. 15 in Salt
Lake City, Utah. The election was by
ballot among members of the Society in
December and January.
Newly elected and installed directors
are:
Catherine M. Bollard, MD, of the
Baylor College of Medicine in Hous-
ton, TX
Jeffrey S. Miller, MD, of the University
of Minnesota in Minneapolis, MN
Paul J. Shaughnessy, MD, of the Texas
Transplant Institute in San Antonio,
TX
All took ofﬁce at the close of the 2013
BMT Tandem Meetings.
Sergio A. Giralt, MD, was elevated to
President-Elect and will assume the
Presidency in 2014. He is the chief of
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Cancer and Allied Diseases, chief of
Adult BMT Service at Memorial Sloan-
Kettering Cancer Center, and professor
of medicine at Weill Cornell Medical
College.
TWO NEW INVESTIGATORS WIN
BBMT EDITORIAL AWARDS
Two medical scientists are the
recipients of editorial awards for new
investigators for their articles published
in 2012 in Biology of Blood and Marrow
Transplantation.
Both are recipients of a $5,000 prize,
supported jointly by grants from
STEMCELL Technologies Inc., and
STEMSOFT Software Inc. Selection of the
winning articles was by the BBMT
Editorial Board and the ASBMT Publi-
cations Committee.
Yeung-Hyen Kim, PhD, is the
winner of the Ernest McCulloch &
James Till Award for best basic science
article by a new investigator. His article
was titled “In Situ Detection
of HY-Speciﬁc T Cells in Acute Graft-
Versus-Host Disease-Affected Male Skin
after Sex-Mismatched Stem Cell
Transplantation.”
Joshua Hill, MD, is recipient of the
George Santos Award for best clinical
science article by a new investigator. His
article was titled “Cord-Blood Hemato-
poietic Stem Cell Transplantation Confers
an Increased Risk for Human
Herpesvirus-6-Associated Acute Limbic
Encephalitis: A Cohort Analysis.”
The awards were presented
by ASBMT’s President, Elizabeth J.
Shpall, MD, during the 2013 BMT
Tandem Meetings in Salt Lake City,
Utah.iety for Blood and Marrow Transplantation.SIX ABSTRACTS CHOSEN AS BEST OF
2013 BMT TANDEM MEETINGS
A total 553 abstracts from 31 coun-
tries were accepted for the 2013 BMT
Tandem Meetings.
Six of the abstracts were selected for
awards by the Abstract Review
Committees.
Recipients of the ASBMT Best
Abstract Awards for Basic Science
Research were:
David Avigan, MD - Blockade of PD-1
in Combination with Dendritic Cell/
Myeloma Fusion Cell Vaccination
following Autologous Stem Cell
Transplantation
Sung Won Choi, MD - Targeting
Deacetylases as a Novel Strategy for
Prevention of Acute GVHD
Yusuke Shono, MD, PhD - Inhibition
of c-Rel Activity Prevents Graft-Versus-
Host Disease without Compromising
Tumor Immunity
Recipients of the CIBMTR Best Ab-
stract Awards for Clinical Research were:
Christopher N. Bredeson, MD, MS -
Improved Survival with Intravenous
Busulfan Compared to Total Body
Irradiation-Based Myeloablative Condi-
tioning Regimens: A CIBMTR Prospec-
tive Study
Ulrike Gerdemann, MD - Safety and
Clinical Efﬁcacy of Rapidly-Generated
Trivirus-Directed T Cells after Alloge-
neic Hematopoietic StemCell Transplant
Gregory Yanik, MD - Competitive
TNF Inhibitor (etanercept) for the
Treatment of Idiopathic Pneumonia
Syndrome following Allogeneic Stem
Cell Transplantation. A Joint Pediatric
Blood and Marrow Transplant Consor-
tium (PBMTC) and Children’s Oncology
Group (COG) Study
The clinical research awards are
supported by a grant fromWellPoint, Inc.
